Effects of topiramate on weight and metabolism in children with epilepsy

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 9, 2009, Pages 1521-1525

  Li, Hai Feng ^b   Zou, Yan ^c   Xia, Zhe Zhi ^a,b   Gao, Feng ^b   Feng, Jian Hua ^b   Yang, Cui Wei ^b  

^a Zhejiang University School of Medicine ^*  (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Adiponectin; Children; Epilepsy; Topiramate

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LEPTIN; LOW DENSITY LIPOPROTEIN; TOPIRAMATE; TRIACYLGLYCEROL;

ARTICLE; BENIGN CHILDHOOD EPILEPSY; BODY MASS; CHILD; CHOLESTEROL BILE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC REGULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADIPONECTIN; ANTI-OBESITY AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; CHILD; EPILEPSY; FEMALE; FRUCTOSE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPIDS; MALE; METABOLISM; STATISTICS, NONPARAMETRIC;

EID: 68649129107     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01349.x     Document Type: Article

References (22)

1. Ben-Menachem E, Axelsen M, Johanson EH, Stagge A, Smith U. Predictors of weight loss in adults with topiramate-treated epilepsy. Obes Res 2003 11 : 556 62.
2. Ogawa Y, Kikuchi T, Nagasaki K, Hiura M, Tanaka Y, Uchiyama M. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese 30. Japanese children. Hypertens Res 2005 28 : 51 7.
3. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006 6 : 772 83.
4. Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001 42 : 796 803.
5. Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, et al. Long-term effects of levetiracetam and topiramate in clinical practice: a head-to-head comparison. Seizure 2008 17 : 19 26.
6. Tremblay A, Chaput JP, Bérubé-Parent S, Prud'homme D, Leblanc C, Alméras N, et al. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. Eur J Clin Pharmacol 2007 63 : 123 34.
7. Klein KM, Theisen F, Knake S, Oertel WH, Hebebrand J, Rosenow F, et al. Topiramate, nutrition and weight change: a prospective study. J Neurol Neurosurg Psychiatry 2008 79 : 590 93.
8. Fredriks AM, Buuren SV, Wit SPV-Body index measurements in 1996-1997 compared with 1980. Arch Dis Child 2000 82 : 107 12.
9. Reiter E, Feucht M, Hauser E, Freilinger M, Seidl R. Changes in body mass index during long-term topiramate therapy in paediatric epilepsy patients-a retrospective analysis. Seizure 2004 13 : 491 93.
10. Miyanishi K, Yamamoto T, Irisa T, Yamashita A, Jingushi S, Noguchi Y, et al. A high low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a potential risk factor for corticosteroid-induced osteonecrosis in rabbits. Rheumatology (Oxford) 2001 40 : 196 201.
11. Burguera B, Couce ME, Long J, Lamsam J, Laakso K, Jensen MD, et al. The long form of the leptin receptor(OB-Rb) is widely expressed in the human brain. Neuroendocrinology 2000 71 : 187 95.
12. Lalonde J, Samson P, Poulin S, Deshaies Y, Richard D. Additive effects of leptin and topiramated in reducing fat deposition in lean and obese oh/oh mice. Physiol Behav 2004 80 : 415 20.
13. Husum H, Van Kammen D, Termeer E, Bolwig G, Mathé A. Topiramate normalizes hippocampal NPY-LI in flinders sensitive line 'depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-inducing effects. Neuropsychopharmacology 2003 28 : 1292 9.
14. Song JH, Tan L, Zhu QX. Influence of topiramate on insulin and leptin levels in epileptic patients. Chin J New Drugs Clin Remedies 2006 25 : 14 6.
15. Basdevant A, Ciangura C. [Leptin: from gene to energy balance]. Bull Acad Natl Med 2007 191 : 887 94 discussion 894 95.
16. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, et al. Proteolitic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Nat Acad Sci USA 2001 98 : 2005 10.
17. Housova J, Anderlova K, Krizová J, Haluzikova D, Kremen J, Kumstyrová T, et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2005 90 : 1366 70.
18. Yang WS, Lee WJ, Funabasshi T. Weight reduction increased plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. Clin Endocrinol Metab 2001 86 : 3815 9.
19. Lee S, Jensen MD. Adipogenic risk factor differences between Korean and white adults-potential role of plasma free fatty acid and adiponectin. Metabolism 2009 58 : 270 4.
20. Diamond FB Jr., Cuthbertson D, Hanna S, Eichler D. Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J Pediatr Endocrinol Metab 2004 17 : 1069 75.
21. Richard D, Picard F, Lemieux C, Lalonde J, Samson P, Deshaies Y. The effects of topiramated and sex hormones on energy balance of male ad female rats. Int J Obes Relat Metab Disord 2002 26 : 344 53.
22. Wilkes JJ, Nguyen MT, Bandyopadhyay GK, Nelson E, Olefsky JM. Topiramate treatment causes skeletal muscle insulin sensitization and increased Acrp30 secretion in high-fat-fed male Wistar rats. Am J Physiol Endocrinol Metab 2005 289 : E1015 22.